Chemokines and chemokine receptors in neurological disease: raise, retain, or reduce? - Wikidata - awgldk - TriplyDB

Chemokines and chemokine receptors in neurological disease: raise, retain, or reduce?

Chemokines and chemokine receptors in neurological disease: raise, retain, or reduce?

http://www.wikidata.org/entity/Q36963161

about

Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain Monocyte migration and LFA-1-mediated attachment to brain microvascular endothelia is regulated by SDF-1 alpha through Lyn kinase Regulation of macrophage biology by lithium: a new look at an old drug Chemokine receptor CXCR2: physiology regulator and neuroinflammation controller?CXCR4/CXCL12 in non-small-cell lung cancer metastasis to the brain Neuropsychiatric Disturbances in Alzheimer's Disease: What Have We Learned from Neuropathological Studies?Neuroinflammation in Alzheimer's disease CCL genes in multiple sclerosis and systemic lupus erythematosus Neuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer's disease Disruption of PKB signaling restores polarity to cells lacking tumor suppressor PTEN.Combining neuropeptide Y and mesenchymal stem cells reverses remodeling after myocardial infarction.Expression and functional significance of SOCS-1 and SOCS-3 in astrocytes Expression and function of CXCL12/CXCR4 in rat urinary bladder with cyclophosphamide-induced cystitis Neuronal I kappa B kinase beta protects mice from autoimmune encephalomyelitis by mediating neuroprotective and immunosuppressive effects in the central nervous system.Neurobiology of microglial action in CNS injuries: receptor-mediated signaling mechanisms and functional roles Prospective study of common variants in CX3CR1 and risk of macular degeneration: pooled analysis from 5 long-term studies.Chemokine CXCL1 enhances inflammatory pain and increases NMDA receptor activity and COX-2 expression in spinal cord neurons via activation of CXCR2.CCL22 regulates experimental autoimmune encephalomyelitis by controlling inflammatory macrophage accumulation and effector function.Central SDF-1/CXCL12 expression and its cardiovascular and sympathetic effects: the role of angiotensin II, TNF-α, and MAP kinase signaling.Cytokines and perinatal brain damage.How to get from here to there: macrophage recruitment in Alzheimer's disease Fractalkine promotes chemotaxis of bone marrow-derived mesenchymal stem cells towards ischemic brain lesions through Jak2 signaling and cytoskeletal reorganization.Fractalkine/CX3CL1 protects striatal neurons from synergistic morphine and HIV-1 Tat-induced dendritic losses and death Central Nervous System and Peripheral Inflammatory Processes in Alzheimer's Disease: Biomarker Profiling Approach.Peripheral chemo-cytokine profiles in Alzheimer's and Parkinson's diseases Inflammatory cell trafficking across the blood-brain barrier: chemokine regulation and in vitro models.Cyclooxygenases-1 and -2 differentially modulate leukocyte recruitment into the inflamed brain.Protein expression profiling of inflammatory mediators in human temporal lobe epilepsy reveals co-activation of multiple chemokines and cytokines NMR in the Analysis of Functional Chemokine Interactions and Drug Discovery CXCL13 drives spinal astrocyte activation and neuropathic pain via CXCR5.Synaptic plasticity in the hippocampus shows resistance to acute ethanol exposure in transgenic mice with astrocyte-targeted enhanced CCL2 expression.Neuroinflammatory response to lipopolysaccharide is exacerbated in mice genetically deficient in cyclooxygenase-2.Pattern of CXCR7 Gene Expression in Mouse Brain Under Normal and Inflammatory Conditions.Expression and function of CCL2/CCR2 in rat micturition reflexes and somatic sensitivity with urinary bladder inflammation Chemokine CXCL13 mediates orofacial neuropathic pain via CXCR5/ERK pathway in the trigeminal ganglion of mice Early degeneration of photoreceptor synapse in Ccl2/Cx3cr1-deficient mice on Crb1(rd8) background Intra-amniotic LPS causes acute neuroinflammation in preterm rhesus macaques.Chemokine levels and chemokine receptor expression in the blood and the cerebrospinal fluid of HIV-infected patients with cryptococcal meningitis and cryptococcosis-associated immune reconstitution inflammatory syndrome.CXCL13/CXCR5 enhances sodium channel Nav1.8 current density via p38 MAP kinase in primary sensory neurons following inflammatory pain Analysis of protein levels of 24 cytokines in scrapie agent-infected brain and glial cell cultures from mice differing in prion protein expression levels

P2860

Q21284848-F3303B6D-109B-44FF-A49E-8120F1D1EECC Q24314285-CE1C439F-4666-4C9F-AB6E-96B542CB5BFA Q26849434-7202B5B8-C5F6-412C-93D1-D0AB19B498B6 Q27007078-F1E4190A-427F-40DB-90FE-67C9E1F59A9C Q27009526-5DCD21AB-DDB6-40FA-B985-E60CC698E3C1 Q28070156-735A087C-E692-45F1-85D3-956428D1DE4C Q28259238-FC9C79F0-7D0A-4F95-B1B0-792B89A64BA8 Q28286163-F86BE15C-74B9-4FCC-ACBF-346FEAA61C3F Q30054419-EA444F8E-CA9B-48BA-B6D2-26B3298189E1 Q30498163-84A8247B-E9BF-4C0B-BAF5-3D8520EC7753 Q33589174-522E15F0-2AD8-46DF-AC2B-7ED251DCB43B Q33717808-DA9C9DEB-3702-407F-92FE-97F4DB835088 Q33727844-FEF47DF8-C6E4-489C-B65A-53B99419E452 Q33893135-F161F03E-09B1-48F4-AB80-B9F416EDA5BA Q34002086-C0A64E6E-FE20-4054-A237-F05DBBF4A77C Q34221997-B6233116-28F4-4A43-BA01-2F655E7904E8 Q34325096-7D9893CB-82B7-4F98-B06D-C3F5AC3330A1 Q34417523-C0D2FBE0-FBED-46A7-B37B-72C932A0E2A5 Q34627822-3A5E1C25-B65D-4108-A776-1D8C6BB23BB2 Q34886336-6B6B4A75-D2D1-4DAA-A887-F2901C743E1E Q34912085-A8CD3EA8-7D78-4A67-89AC-8001B21FB8CA Q35537994-991EADEB-2BA1-4F9D-AEB3-85965E5751C0 Q35779848-5D8F80B6-9C33-4384-A826-D8DA611E1841 Q35990600-62311AF3-EE2F-449F-9AB5-72193E3B438D Q36023238-6A662664-3C90-4907-B8D8-67772517821A Q36059965-D844B79B-8E96-4584-9975-3D02A4E835F4 Q36067379-C62C9E09-DEAC-4E64-AE7F-91C4DBADB2D4 Q36372950-B5E767A2-B5BB-4D65-AEFA-18E27524A3B5 Q36403522-934A0011-D342-45D1-A504-7565AF3F4052 Q36515088-05B12775-AFCE-45E4-8E54-656F047B2713 Q36677540-1DC44995-81B8-41A1-A38C-B6D70B1569AC Q36693623-8C495B6B-23B3-443E-B3F2-A3A1634F9390 Q36798278-19238655-00AD-4C2E-B08E-3642F432B1F8 Q37051472-9E39A516-93DB-46B7-9B73-A70AEE4615C3 Q37084908-35EEDCDE-48EE-4E9A-BEA6-A6BC465F28BA Q37100308-022F799F-561D-4B09-B143-54D9FB3AD167 Q37233202-090169E9-3382-4FB3-99F5-764A3C605952 Q37247472-E4E41877-AFAF-417F-8CBC-03B4FDE59D49 Q37314840-76FE1FDC-764F-4626-8924-42910E866980 Q37410864-C02833D7-828E-4F94-A9D0-371645B2BE13

P2860

Chemokines and chemokine receptors in neurological disease: raise, retain, or reduce?

http://www.wikidata.org/entity/Q36963161

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Chemokines and chemokine receptors in neurological disease: raise, retain, or reduce?

@en

type

label

Chemokines and chemokine receptors in neurological disease: raise, retain, or reduce?

@en

prefLabel

Chemokines and chemokine receptors in neurological disease: raise, retain, or reduce?

@en

P1433

Q36963161-9597FB10-ED57-4E9F-A3C0-18A6A815DA24

P1476

Q36963161-467881CF-0FAD-493E-958A-908E722D87E6

P2093

Q36963161-A8E0D3A9-02C1-4F59-8FB6-66CD95EF055C

Q36963161-B2E7B7A4-7EB0-4EF2-BB0D-B59C0CE2DCAF

P2860

Q36963161-02A6ABA6-2712-4271-BB7D-57E4FA6E9A62

Q36963161-05699139-ACCB-45C1-BA37-0B48D27BFB96

Q36963161-05D48BA3-85A7-47FC-9F08-86519C3E6D8D

Q36963161-07453EC3-13C8-4A6B-B0B0-3C8441C0CCA7

Q36963161-0C779EB3-8868-4C2D-849B-5A5F0DCCF291

Q36963161-0DC8E835-6859-48E9-B5E0-4774AD6DE40C

Q36963161-1619EE3C-9B03-47C2-B852-728E9B3F7135

Q36963161-17EC36E6-75BE-4447-9B25-4E433CC74985

Q36963161-1C2E14D4-947E-4B96-8260-020D4D070DEE

Q36963161-20F58D4E-CB5C-4917-8F34-6B655F967285

P2888

Q36963161-1DFB5C24-B2C1-4078-9DCA-8E1CADFE1973

P304

Q36963161-26DFB1DB-2A57-4566-BE0E-471B3476D8A0

P31

Q36963161-E39BCE3E-293B-44A5-B606-CCC51621B44F

P356

Q36963161-EAC5853F-8A62-4396-83DF-F6CECD033A12

P433

Q36963161-C4F20201-8BD6-4AFD-83F8-F3BCA4AE2E84

P478

Q36963161-86580D98-65DF-4FAC-BCBD-0DAAC208B784

P577

Q36963161-A401572B-3A75-46FD-A985-17B59A997FC8

P5875

Q36963161-C8CC0B36-B5D8-42B7-88B2-FC7F3AE4C3FF

P6179

Q36963161-D93608FD-053B-44EF-A9E3-2BF9B7E5427C

P698

Q36963161-E89E8CEF-0903-4A07-B9DC-93A3AFEAE6E0

P356

J.NURT.2007.07.004

P1433

Neurotherapeutics

P1476

Chemokines and chemokine receptors in neurological disease: raise, retain, or reduce?

@en

P2093

Carine Savarin-Vuaillat

http://www.w3.org/2001/XMLSchema#string

Richard M Ransohoff

http://www.w3.org/2001/XMLSchema#string

P2860

Involvement of chemokine receptors in breast cancer metastasis

Structure and functional expression of a human interleukin-8 receptor

Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients

The MCP/eotaxin subfamily of CC chemokines

The chemokine receptor CXCR2 controls positioning of oligodendrocyte precursors in developing spinal cord by arresting their migration

Lymphotactin: a cytokine that represents a new class of chemokine

A new class of membrane-bound chemokine with a CX3C motif

Identification and characterization of a potent, selective, and orally active antagonist of the CC chemokine receptor-1

The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract

Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development

P2888

j.nurt.2007.07.004

P304

590-601

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NURT.2007.07.004

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2007-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5923590

http://www.w3.org/2001/XMLSchema#string

P6179

1039894617

http://www.w3.org/2001/XMLSchema#string

P698

17920540

http://www.w3.org/2001/XMLSchema#string